A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Public ClinicalTrials.gov record NCT02104674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase III, randomized, double-blind, placebo-controlled, multicenter study will assess the efficacy and safety of lebrikizumab in adult patients with mild to moderate asthma treated with short-acting beta-agonist (SABA) therapy alone. Patients will be randomized in a 1:1:1 ratio to receive either blinded lebrikizumab or placebo treatment by subcutaneous (SC) injection (every 4 weeks for a total of 3 doses) or open-label treatment with Singulair (Montelukast; 10 mg daily). Time on study treatment will last 12 weeks.
Study identification
- NCT ID
- NCT02104674
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 7, 2014 (Actual)
- Primary completion
- Jan 22, 2016 (Actual)
- Completion
- Jan 22, 2016 (Actual)
- Last update posted
- Jul 17, 2026
2014 – 2016
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama, LLC | Birmingham | Alabama | 35209 | — |
| Allergy & Asthma Immunology Associates | Scottsdale | Arizona | 85251 | — |
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| CA Allergy & Asthma Med Grp; Medical Group, Inc. | Los Angeles | California | 90025 | — |
| Southern California Institute For Respiratory | Los Angeles | California | 90048 | — |
| North Bay Clinical Trials | Napa | California | 94558 | — |
| Advances in Medicine | Rancho Mirage | California | 92270 | — |
| Allergy & Asthma Consultants | Redwood City | California | 94063 | — |
| Integrated Research Group Inc | Riverside | California | 92506 | — |
| Storms Clinical Research; Institute | Colorado Springs | Colorado | 80907 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| Florida Pulmonary Research Institute, LLC | Winter Park | Florida | 32789 | — |
| In-Quest Medical Research, LLC | Duluth | Georgia | 30096 | — |
| Sneeze, Wheeze, & Itch Associates | Normal | Illinois | 61761 | — |
| Asthma & Allergy Center of Chicago, S.C. | River Forest | Illinois | 60305 | — |
| Family Allergy & Asthma | Louisville | Kentucky | 40223 | — |
| Midwest Clinical Research LLC | St Louis | Missouri | 63141 | — |
| The Clinical Research Ctr | St Louis | Missouri | 63141 | — |
| Asthma & Allergy Center, P.C. | Papillion | Nebraska | 68046 | — |
| Advanced Research Institute | Reno | Nevada | 89511 | — |
| Atlantic Research Center, LLC | Ocean City | New Jersey | 07712 | — |
| Urban Health Plan, Inc. | The Bronx | New York | 10459 | — |
| Allergy, Asthma & Clinical Research Center | Oklahoma City | Oklahoma | 73120 | — |
| Clinical Research Inst. of Southern Oregon, Pc | Medford | Oregon | 97504 | — |
| Allergy Associates Research Center LLC - CRN | Portland | Oregon | 97202 | — |
| Mountainview Clinical Research | Greer | South Carolina | 29651 | — |
| TTS Research | Boerne | Texas | 78006 | — |
| Allergy Asthma Research Assoc | Dallas | Texas | 75231 | — |
| Pharmaceutical Research & Consulting, Inc. | Dallas | Texas | 75231 | — |
| Texas Institute of chest and Sleep Disorder | Houston | Texas | 77034 | — |
| Metroplex Pulmonology & Sleep Center | McKinney | Texas | 75069 | — |
| Quality Assurance Research Center | San Antonio | Texas | 78207 | — |
| Bandera Family Health Care | San Antonio | Texas | 78249 | — |
| South Texas Allergy and Asthma Medical Professionals | San Antonio | Texas | 78251 | — |
| Allergy & Asthma Center | Waco | Texas | 76712 | — |
| O & O Alpan, LLC | Fairfax | Virginia | 22030 | — |
| Clinical Research Partners, LLC | Richmond | Virginia | 23220 | — |
| Allergy Asthma & Sinus Center | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02104674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2026 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02104674 live on ClinicalTrials.gov.